The endogenous bacteria alter gut epithelial apoptosis and decrease mortality following pseudomonas aeruginosa pneumonia

Shock

Volumn 38, Issue 5, 2012, Pages 508-514

  Fox, Amy C ^a   McConnell, Kevin W ^b   Yoseph, Benyam P ^b   Breed, Elise ^b   Liang, Zhe ^b   Clark, Andrew T ^a   O'Donnell, David ^c   Zee Cheng, Brendan ^a   Jung, Enjae ^a   Dominguez, Jessica A ^a   Dunne, W Michael ^a   Burd, Eileen M ^b   Coopersmith, Craig M ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Center for Genome Sciences and Systems Biology   (United States)

Author keywords

apoptosis; commensal microflora; endogenous bacteria; germ free; gut; intestine; pneumonia; Sepsis

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL FLORA; BACTERIAL IMMUNITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DILUTION; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; LUNG LAVAGE; MORTALITY; MOUSE; NONHUMAN; PROTEIN CONTENT; PSEUDOMONAS PNEUMONIA; SEPSIS; SURVIVAL TIME; WILD TYPE;

ANIMALS; APOPTOSIS; GERM-FREE LIFE; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEPSIS;

EID: 84868207549     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31826e47e8     Document Type: Article

References (39)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303-1310, 2001.
2. Clark JA, Coopersmith CM: Intestinal crosstalk: a new paradigm for understanding the gut as the Bmotor of critical illness. Shock 28(4):384-393, 2007.
3. Dominguez JA, Coopersmith CM: Can we protect the gut in critical illness? The role of growth factors and other novel approaches. Crit Care Clin 26(3): 549-565, 2010.
4. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA: Post-injury multiple organ failure: the role of the gut. Shock 15(1):1-10, 2001.
5. Dominguez JA, Vithayathil PJ, Khailova L, Lawrance CP, Samocha AJ, Jung E, Leathersich AM, Dunne WM, Coopersmith CM: Epidermal growth factor improves survival and prevents intestinal injury in a murine model of Pseudomonas aeruginosa pneumonia. Shock 36(4):381-389, 2011.
6. Yu P, Martin CM: Increased gut permeability and bacterial translocation in Pseudomonas pneumoniaYinduced sepsis. Crit Care Med 28:2573-2577, 2000.
7. NealMD, Leaphart C, Levy R, Prince J, Billiar TR, Watkins S, Li J, Cetin S, Ford H, Schreiber A, et al.: Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 176(5):3070-3079, 2006.
8. Clark JA, Clark AT, Hotchkiss RS, Buchman TG, Coopersmith CM: Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis. Shock 30(1):36-42, 2008.
9. Clark JA, Gan H, Samocha AJ, Fox AC, Buchman TG, Coopersmith CM: Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis. Am J Physiol Gastrointest Liver Physiol 297(3):G471-G479, 2009.
10. Ley RE, Peterson DA, Gordon JI: Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124(4):837-848, 2006.
11. Medzhitov R: Recognition of microorganisms and activation of the immune response. Nature 449(7164):819-826, 2007.
12. Mueller C, Macpherson AJ: Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 55(2):276-284, 2006.
13. Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MA, Geuking MB, Beutler B, Tedder TF, Hardt WD, et al.: Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 25(5940):617-620, 2009.
14. Steele L, Mayer L, Cecilia BM: Mucosal immunology of tolerance and allergy in the gastrointestinal tract [published online ahead of print March 24, 2012]. Immunol Res 2012.
15. Wells CL, Hess DJ, Erlandsen SL: Impact of the indigenous flora in animal models of shock and sepsis. Shock 22(6):562-568, 2004.
16. Morrow LE, Gogineni V, Malesker MA: Probiotic, prebiotic, and synbiotic use in critically ill patients. Curr Opin Crit Care 18:186-191, 2012.
17. Schultz MJ, Haas LE: Antibiotics or probiotics as preventive measures against ventilator-associated pneumonia: a literature review. Crit Care 15(1):R18, 2011.
18. Fagundes CT, Amaral FA, Vieira AT, Soares AC, Pinho V, Nicoli JR, Vieira LQ, Teixeira MM, Souza DG: Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J Immunol 188(3):1411-1420, 2012.
19. Chen LW, Chen PH, Hsu CM: Commensal microflora contribute to host defense against Escherichia coli pneumonia through Toll-like receptors. Shock 36(1):67-75, 2011.
20. Morrow LE, Kollef MH, Casale TB: Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 182(8):1058-1064, 2010.
21. Tan M, Zhu JC, Du J, Zhang LM, Yin HH: Effects of probiotics on serum levels of TH1/TH2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Crit Care 15(6):R290, 2011.
22. Ferraro FJ, Rush BF Jr, Simonian GT, Bruce CJ, Murphy TF, Hsieh JT, Klein K, Condon M: A comparison of survival at different degrees of hemorrhagic shock in germ-free and germ-bearing rats. Shock 4(2):117-120, 1995.
23. Souza DG, Vieira AT, Soares AC, Pinho V, Nicoli JR, Vieira LQ, Teixeira MM: The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 173(6):4137-4146, 2004.
24. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, et al.: Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360(1):20-31, 2009.
25. Silvestri L, van Saene HK, Milanese M, Gregori D, Gullo A: Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J Hosp Infect 65(3):187-203, 2007.
26. Yang R, Gallo DJ, Baust JJ, Watkins SK, Delude RL, Fink MP: Effect of hemorrhagic shock on gut barrier function and expression of stress-related genes in normal and gnotobiotic mice. Am J Physiol Regul Integr Comp Physiol 283(5):R1263-R1274, 2002.
27. Diebel LN, Liberati DM, Dulchavsky SA, Diglio CA, Brown WJ: Enterocyte apoptosis and barrier function are modulated by SIgA after exposure to bacteria and hypoxia/reoxygenation. Surgery 134(4):574-580, 2003.
28. Kerneis S, Bogdanova A, Kraehenbuhl JP, Pringault E: Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 277(5328):949-952, 1997.
29. Stromberg PE, Woolsey CA, Clark AT, Clark JA, Turnbull IR, McConnell KW, Chang KC, Chung CS, Ayala A, Buchman TG, et al.: CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. FASEB J 23(6): 1817-1825, 2009.
30. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI: The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1(6):6ra14, 2009.
31. Fox AC, Breed ER, Liang Z, Clark AT, Zee-Cheng BR, Chang KC, Dominguez JA, Jung E, Dunne WM, Burd EM, et al.: Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality. J Immunol 187(4):1950-1956, 2011.
32. Fox AC, Robertson CM, Belt B, Clark AT, Chang KC, Leathersich AM, Dominguez JA, Perrone EE, Dunne WM, Hotchkiss RS, et al.: Cancer causes increased mortality and is associated with altered apoptosis in murine sepsis. Crit Care Med 38(3):886-893, 2010.
33. McConnell KW, McDunn JE, Clark AT, Dunne WM, Dixon DJ, Turnbull IR, Dipasco PJ, Osberghaus WF, Sherman B, Martin JR, et al.: Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses. Crit Care Med 38:223-241, 2010.
34. Wang L, Srinivasan S, Theiss AL, Merlin D, Sitaraman SV: Interleukin-6 induces keratin expression in intestinal epithelial cells: potential role of keratin-8 in interleukin-6Yinduced barrier function alterations. J Biol Chem 282(11): 8219-8227, 2007.
35. Ostman S, Rask C, Wold AE, Hultkrantz S, Telemo E: Impaired regulatory T cell function in germ-free mice. Eur J Immunol 36(9):2336-2346, 2006.
36. Macpherson AJ, Geuking MB, McCoy KD: Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 115(2): 153-162, 2005.
37. Shimizu K, Ogura H, Hamasaki T, Goto M, Tasaki O, Asahara T, Nomoto K, Morotomi M, Matsushima A, Kuwagata Y, et al.: Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci 56(4):1171-1177, 2011.
38. Alverdy JC, Chang EB: The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away. J Leukoc Biol 83(3):461-466, 2008.
39. Turnbull IR, Clark AT, Stromberg PE, Dixon DJ, Woolsey CA, Davis CG, Hotchkiss RS, Buchman TG, Coopersmith CM: Effects of aging on the immunopathologic response to sepsis. Crit Care Med 7(3):1018-1023, 2003.